IUHSA
PRQR icon

Itau Unibanco Holding S.A.’s ProQR Therapeutics PRQR Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,971
Closed -$6K – 579
2022
Q1 		$6K Hold
6,971
– – ﹤0.01% 441
2021
Q4 		$57K Sell
6,971
-2,508
-26% -$19.1K ﹤0.01% 273
2021
Q3 		$79K Buy
9,479
+3,120
+49% +$20.4K ﹤0.01% 212
2021
Q2 		$43K Buy
+6,359
New +$41K ﹤0.01% 202

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Itau Unibanco Holding S.A.'s PRQR Position: Q2 2022 in Review

Itau Unibanco Holding S.A. sold out of ProQR Therapeutics (PRQR) in Q2 2022, closing a stake of 6,971 shares — an estimated $6K sold.

Itau Unibanco Holding S.A. first reported a position in PRQR in Q2 2021 and held it in 4 quarters. The position peaked at $79K in Q3 2021. 51 funds tracked by Wall St. Rank hold PRQR as of Q2 2022.

  • Itau Unibanco Holding S.A. reported no remaining ProQR Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 6,971 ProQR Therapeutics shares in Q2 2022, an estimated $6K.
  • Itau Unibanco Holding S.A. first reported a position in ProQR Therapeutics in Q2 2021 and held it in 4 quarters.
  • Itau Unibanco Holding S.A.'s ProQR Therapeutics position peaked at $79K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2022.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2022, filed 15 Aug 2022.